NIH-funded research Fellowship grant

Improving access to personalized medicine for rural and underserved communities

Official title: Ensuring Equity in Pharmacogenetics for Rural and Underserved Communities

Funded at University of Montana · NIH-10998474 · Data updated 2026-11-12

This study is looking at how to make personalized medicine better for people in rural and underserved areas of Montana by understanding how doctors prescribe certain medications and how genetic testing can help improve treatment options for everyone.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Montana
NIH-funded
Lab location1 site (Missoula, United States)
Project startNovember 2, 2024
Project endOctober 31, 2027
Funding year2024
Award (this year)$78,954
NIH project number1F32HG013895-01
Project IDNIH-10998474 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals living in rural or underserved communities who may benefit from personalized medication approaches.

Less likely to help

Patients living in urban areas or those who already have access to pharmacogenetic testing may not receive significant benefits from this research.

What this research studies

This research investigates how pharmacogenetics (PGx) can be effectively implemented in rural and underserved communities in Montana. It focuses on understanding the prescribing patterns of PGx medications and the clinical utility of PGx testing among healthcare providers. By conducting surveys and analyzing data, the project aims to identify barriers to access and improve the personalized approach to drug treatment for these populations. The ultimate goal is to ensure that innovations in drug prescribing are equitably available to all communities.

Why it matters

Potential benefit: If successful, this research could lead to improved medication effectiveness and safety for patients in rural and underserved areas.

How similar studies have gone: Previous research has shown that implementing pharmacogenetic testing can improve treatment outcomes, suggesting that this approach may be effective in similar contexts.

Where this research is happening

  • University of Montana
    Missoula, United States
    Active

Researchers

  • Principal investigator: Killam, Shayna Rae — University of Montana
  • Study coordinator: Killam, Shayna Rae

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.